Frequently Asked Questions
The market is segmented based on Segmentation, By Source (Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells (hESCs), Bone Marrow-Derived Stem Cells (BMSCs), Dental Pulp-Derived Stem Cells (DPSCS), Adipose Tissue-Derived Stem Cells (ADSCs), Other Stem Cell Sources), Product (Adult Stem Cells, Human Embryonic Cells, IPS Cells), Bank Type (Private, Public), Service Type (Sample Collection and Transportation, Sample Processing, Sample Analysis, Sample Preservation, Storage), Utilization (Used, Unused), Application (Personalized Storage, Clinical, Research) – Industry Trends and Forecast to 2031.
.
The Global Stem Cell Banking Market size was valued at USD 6.73 USD Billion in 2023.
The Global Stem Cell Banking Market is projected to grow at a CAGR of 16.1% during the forecast period of 2024 to 2031.
The major players operating in the market include CBR Systems , Cordlife, Cryo-Cell International , ViaCord, Cryo-Save, LifeCell International Pvt. , StemCyte India Therapeutics Pvt. Ltd, Global Cord Blood Corporation, Smart Cells International Limited, Vita34 1997, Caladrius Biosciences , Celgene Corporation, BrainStorm Cell Limited, Regrow Biosciences Pvt. , CryoHoldco-.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
